re: Ann: Third Supplementary Target's Sta... A well written statement. Probably the best thing I've read from MAK in this battle, kudos to Lawrenson for the change in tone. I don't think it will be long before UCL change their bid, i would expect very shortly after their Takeover Panel review hearing. We can then see how it will play out but by the tone here UCL will have achieved one objective of ensuring MAK don't launch another aggressive move against them - at least without strong backing. I'd estimate a month or so to go in this.
- Forums
- ASX - By Stock
- Ann: Third Supplementary Target's Statement
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
0.8¢ |
Change
-0.001(11.1%) |
Mkt cap ! $25.42M |
Open | High | Low | Value | Volume |
0.9¢ | 0.9¢ | 0.8¢ | $3.935K | 437.3K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
11 | 7234999 | 0.8¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.9¢ | 202000 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
11 | 7234999 | 0.008 |
5 | 3147490 | 0.007 |
5 | 2585000 | 0.006 |
2 | 1300000 | 0.005 |
2 | 1450000 | 0.004 |
Price($) | Vol. | No. |
---|---|---|
0.009 | 202000 | 2 |
0.010 | 6540823 | 13 |
0.011 | 1100099 | 2 |
0.012 | 2544954 | 2 |
0.013 | 1234269 | 4 |
Last trade - 16.10pm 04/07/2025 (20 minute delay) ? |
Featured News
AEV (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Dr Michael Thurn, CEO & MD
Dr Michael Thurn
CEO & MD
SPONSORED BY The Market Online